AUTONOMY BIO

What this means for you

Not registered yet, but its 18 Feb 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

99046434

Mark type

Stylized text

Filed

18 Feb 2025

Attorney of record

Ranjini Acharya

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for anti-aging, including drugs formulated to delay or reverse age-related physiological decline; Prescription and over-the-counter medications for preventing or delaying human aging; Pharmaceutical compounds designed for reducing or reversing declines associated with aging; Therapeutic agents for improving skin and systemic health through pharmaceutical intervention; Medical preparations for increasing healthspan and lifespan.; Gene therapy products, namely, genetically engineered tissues for anti-aging purposes; Stem cells for medical purposes; Biologic tissue products, namely, genetically engineered tissues and stem cells for use in regenerative medicine; Nutraceuticals for use as a dietary supplement for delaying or reversing age-related decline; Pharmaceutical products for the personalized treatment for delaying or reversing age-related decline; Wearable drug delivery devices sold filled with pharmaceutical preparations for delaying or reversing age-related decline; Dietary supplements, protein supplements, and protein peptide supplements all containing amino acids as peptides; Dietary and nutritional supplements; Implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for delaying or reversing age-related decline
• Class 042 — Scientific and technological services: Pharmaceutical research and development services focusing on anti-aging and longevity therapeutics; Drug discovery platform as a service (PaaS) featuring a computer software platform for identifying drug synergies and optimizing clinical trial protocols; Scientific research and consulting in the field of gerontology and human anti-aging.; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Stem cell research services; Providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence (AI) for use in machine learning for predicting and optimizing human lifespan; Performing scientific research or providing scientific research services to identify novel biomarkers to aid in new drug development and clinical trial processes related to delaying or reversing age-related decline; Consulting services for others in the field of design, planning, and implementation project management of clinical trials for anti-aging drugs
• Class 044 — Medical, beauty and agricultural services: Stem cell therapy services; Regenerative medicine services

Owner

• Autonomy Bio, Inc., San Francisco, CA, US

Prosecution history

• 20 Jan 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
• 20 Jan 2026 — SUSPENSION LETTER WRITTEN
• 16 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 16 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 16 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 08 Oct 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
• 08 Oct 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
• 31 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 31 Jul 2025 — NON-FINAL ACTION E-MAILED
• 31 Jul 2025 — NON-FINAL ACTION WRITTEN
• 24 Jul 2025 — ASSIGNED TO EXAMINER
• 18 Feb 2025 — APPLICATION FILING RECEIPT MAILED
• 18 Feb 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 18 Feb 2025 — NEW APPLICATION ENTERED
• 20 Jan 2026 — LETTER OF SUSPENSION E-MAILED